T 1914/16 (Ciclesonide/COVIS) of 20.02.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T191416.20200220
- Date of decision
- 20 February 2020
- Case number
- T 1914/16
- Online on
- 14 May 2020
- Petition for review of
- -
- Application number
- 04766791.0
- IPC class
- A61K 31/57A61K 31/58A61K 9/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
- Applicant name
- Covis Pharma B.V.
- Opponent name
- Generics [UK] Ltd (trading as Mylan)
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 123(2) (2007)
- Keywords
- main request - allowable
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted thereto:
claims 1 to 18 of the main request, filed at the oral proceedings of 20 February 2020.